Klebsiella pneumoniae, Antimicrobial resistance, Clinical epidemiology
SARS-CoV-2, COVID-19, pandemic, respiratory tract infection (LRTI)
Pneumococcal conjugate vaccine, reduced-dose schedule, non-inferiority, long-term immunogenicity, South Africa, HIV-unexposed, PCV13, PCV10